179 related articles for article (PubMed ID: 11843929)
1. The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.
Dowley AC; Homer JJ
Clin Otolaryngol Allied Sci; 2001 Dec; 26(6):488-90. PubMed ID: 11843929
[TBL] [Abstract][Full Text] [Related]
2. Effects of oxymetazoline on nasal flow and maximum aerobic exercise performance in patients with inferior turbinate hypertrophy.
Gómez-Hervás J; García-Valdecasas Bernal J; Fernández-Prada M; Palomeque-Vera JM; García-Ramos A; Fernández-Castanys BF
Laryngoscope; 2015 Jun; 125(6):1301-6. PubMed ID: 25546052
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging.
Pritchard S; Glover M; Guthrie G; Brum J; Ramsey D; Kappler G; Thomas P; Stuart S; Hull D; Gowland P
Pulm Pharmacol Ther; 2014 Feb; 27(1):121-6. PubMed ID: 23988443
[TBL] [Abstract][Full Text] [Related]
4. Sinonasal distribution of topically applied particles: computerized tomographic detection and the effects of topical decongestion.
Senocak D; Senocak M; Bozan S
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):944-8. PubMed ID: 16360518
[TBL] [Abstract][Full Text] [Related]
5. Radiological comparison of inferior turbinate hypertrophy between allergic and non-allergic rhinitis: does allergy really augment turbinate hypertrophy?
Sharhan SSA; Lee EJ; Hwang CS; Nam JS; Yoon JH; Kim CH; Cho HJ
Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):923-929. PubMed ID: 29417277
[TBL] [Abstract][Full Text] [Related]
6. Isolated Topical Decongestion of the Nasal Septum and Swell Body Is Effective in Improving Nasal Airflow.
Wong E; Deboever N; Chong J; Sritharan N; Singh N
Am J Rhinol Allergy; 2020 May; 34(3):417-421. PubMed ID: 32008353
[No Abstract] [Full Text] [Related]
7. The assessment of topical nasal drug distribution.
Aggarwal R; Cardozo A; Homer JJ
Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):201-5. PubMed ID: 15142061
[TBL] [Abstract][Full Text] [Related]
8. How Does Oxymetazoline Change Nasal Aerodynamics and Symptomatology in Patients with Turbinate Hypertrophy?
Root ZT; Lepley TJ; Wu Z; Chapman RJ; Schneller AR; Formanek VL; Kelly KM; Otto BA; Zhao K
Laryngoscope; 2024 Mar; 134(3):1100-1106. PubMed ID: 37589314
[TBL] [Abstract][Full Text] [Related]
9. Use of peak nasal inspiratory flowmetry and nasal decongestant to evaluate outcome of septoplasty with radiofrequency coblation of the inferior turbinate.
Balikci HH; Gurdal MM
Rhinology; 2014 Jun; 52(2):112-115. PubMed ID: 24932620
[TBL] [Abstract][Full Text] [Related]
10. Reversible nasal airway obstruction: does change in nasal peak inspiratory flow following decongestion predict response to topical steroids in chronic rhinosinusitis patients?
Koo Ng NK; Young D; McGarry GW
J Laryngol Otol; 2012 Dec; 126(12):1238-40. PubMed ID: 23057871
[TBL] [Abstract][Full Text] [Related]
11. Impact of inferior turbinate hypertrophy on the aerodynamic pattern and physiological functions of the turbulent airflow - a CFD simulation model.
Chen XB; Lee HP; Chong VF; Wang de Y
Rhinology; 2010 Jun; 48(2):163-8. PubMed ID: 20502754
[TBL] [Abstract][Full Text] [Related]
12. An endoscopic photographic comparison of nasal drug delivery by aqueous spray.
Homer JJ; Raine CH
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):560-3. PubMed ID: 9884813
[TBL] [Abstract][Full Text] [Related]
13. Changes of airflow pattern in inferior turbinate hypertrophy: a computational fluid dynamics model.
Lee HP; Poh HJ; Chong FH; Wang de Y
Am J Rhinol Allergy; 2009; 23(2):153-8. PubMed ID: 19401040
[TBL] [Abstract][Full Text] [Related]
14. A quantitative analysis of the intranasal delivery of topical nasal drugs to the middle meatus: spray versus drop administration.
Homer JJ; Maughan J; Burniston M
J Laryngol Otol; 2002 Jan; 116(1):10-3. PubMed ID: 11860644
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of anterior rhinomanometry in diode laser turbinoplasty.
Volk GF; Pantel M; Guntinas-Lichius O; Wittekindt C
Arch Otolaryngol Head Neck Surg; 2010 Oct; 136(10):1015-9. PubMed ID: 20956750
[TBL] [Abstract][Full Text] [Related]
16. [Radiofrequency ablation for treatment of nasal obstruction secondary to inferior turbinate hypertrophy].
Li W; Zhang L; Xu J; Tang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Nov; 17(11):663-4. PubMed ID: 14971202
[TBL] [Abstract][Full Text] [Related]
17. Prediction of outcome of radiofrequency ablation of the inferior turbinates.
Sahin-Yilmaz A; Oysu Ç; Devecioglu I; Demir K; Corey JP
Int Forum Allergy Rhinol; 2014 Jun; 4(6):470-4. PubMed ID: 24532568
[TBL] [Abstract][Full Text] [Related]
18. Compensatory hypertrophy of the contralateral inferior turbinate in patients with unilateral nasal septal deviation. A computed tomography study.
Chiesa Estomba C; Rivera Schmitz T; Ossa Echeverri CC; Betances Reinoso FA; Osorio Velasquez A; Santidrian Hidalgo C
Otolaryngol Pol; 2015; 69(2):14-20. PubMed ID: 26224225
[TBL] [Abstract][Full Text] [Related]
19. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
[TBL] [Abstract][Full Text] [Related]
20. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
Druce HM; Ramsey DL; Karnati S; Carr AN
Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
